-- 
Spanish Stocks: Santander, BBVA, Inditex, Mapfre, Solaria Move

-- B y   A l e x i s   X y d i a s   a n d   M a n u e l   B a i g o r r i
-- 
2011-03-29T16:04:07Z

-- http://www.bloomberg.com/news/2011-03-29/spanish-stocks-bbva-banco-santander-inditex-shares-move.html
Spain ’s IBEX 35 index dropped 16,
or 0.2 percent, to 10,735 at the 5:30 p.m. close in Madrid. The
Madrid Stock Exchange General Index fell 0.3 percent.  The following were among the most active stocks in the
Spanish market. Symbols are in parentheses after company names.  Banco Bilbao Vizcaya Argentaria SA (BBVA)   fell 1.5
percent to 8.85 euros, erasing yesterday’s gain. Spanish lenders
fell as Greece and Portugal’s credit ratings were cut by
 Standard & Poor’s .  Banco Santander SA (SAN)   dropped 1.3
percent to 8.45 euros.  Banco Popular Espanol SA (POP)   slid
1.4 percent to 4.3 euros.  Bankinter SA (BKT)   slipped 1.2
percent to 5.02 euros.  Inditex SA (ITX)  , Spain’s largest clothing retailer,
rose 1.3 percent to 57.54 euros. Cotton prices yesterday tumbled
the most allowed by ICE Futures U.S. on speculation that global
production will climb.  Mapfre SA (MAP)   fell for a third day, losing 1.9 percent
to 2.66 euros. Spain’s biggest insurer company bought 12.5
percent of Mapfre International from Caja Madrid and Caja Madrid
bought 48.97 percent of Banco Servicios Financieros from Mapfre,
Mapfre and Caja Madrid said in a regulatory filing.  Nicolas Correa SA (NEA)   rose 5.1 percent to 2.05 euros,
the steepest gain in more than two months. Spain’s largest maker
of milling machines will return to profit in the second half of
this year after it completes the reshuffle of its management
team and reduces the number of products it manufactures, El
Confidencial said, citing Chairman Jose Ignacio Nicolas Correa.  Solaria Energia & Medio Ambiente SA (SLR SM) soared for a
sixth day, jumping 5.7 percent to 2.58 euros. Solar-panel
installations may rise by more than 50 percent this year,
matching Apple Inc.’s 2010 sales increase after launching the
iPad, as the technology emerges as a mainstream consumer
product.  Zeltia SA (ZEL)   fell 0.7 percent to 2.81 euros, erasing
yesterday’s gain. The Spanish developer of cancer drugs from sea
creatures was downgraded to “accumulate” from “buy” at Caja
Madrid Bolsa.  To contact the reporter on this story:
Alexis Xydias in London at 
 axydias@bloomberg.net ;
Manuel Baigorri in Madrid at 
 mbaigorri@bloomberg.net   To contact the editor responsible for this story:
Andrew Rummer at 
 arummer@bloomberg.net  